TrialJournal of health, population, and nutrition2024

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Atsuhiro Kishimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.